Genetics of the serotonergic system in suicidal behavior

Journal of Psychiatric Research

Volumn 37, Issue 5, 2003, Pages 375-386

  Arango, Victoria ^a,b   Huang, Yung Yu ^a,b   Underwood, Mark D ^a,b   Mann, J John ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ALCOHOLISM; ALLELE; BINDING SITE; CADAVER; CHROMOSOME 17; DNA FLANKING REGION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NEUROTRANSMITTER RELEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR;

EID: 0038383793     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00048-7     Document Type: Article

References (118)

1. Abbar M., Courtet P., Bellivier F., Leboyer M., Boulenger J.P., Castelhau D.et al. Suicide attempts and the tryptophan hydroxylase gene. Mol. Psychiatry. 6:2001;268-273.
2. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Archives of General Psychiatry. 47:1990;1038-1047.
3. 1D sites is reduced in prefrontal cortex of alcoholics. Society for Neuroscience Abstracts. 21:1995;1732.
4. Arango V., Mann J.J. Relevance of serotonergic postmortem studies to suicidal behavior. International Review of Psychiatry. 4:1992;131-140.
5. Arango V., Underwood M.D. Serotonin chemistry in the brain of suicide victims. Mans R., Silverman M., Canetto S. Review of Suicidology. 1997;Guilford Press, New York.
6. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., Mann J.J. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 25:2001;892-903.
7. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research. 688:1995;121-133.
8. Arango V., Underwood M.D., Mann J.J. Postmortem findings in suicide victims. Implications for in vivo imaging studies. Annals of the New York Academy of Sciences. 836:1997;269-287.
9. 2 receptors in suicide victims. Biological Psychiatry. 35:1994;457-463.
10. Asberg M., Nordstrom P., Irãskman-Bendz L. Cerebrospinal fluid studies in suicide. An overview. Annals of the New York Academy of Sciences. 487:1986;243-255.
11. Beck A.T., Kovacs M., Weissman A. Assessment of suicidal intention. the scale for suicide ideation Journal of Consulting and Clinical Psychology. 47:1979;343-352.
12. Beck A.T., Steer R.A., Kovacs M., Garrison B. Hopelessness and eventual suicide. a 10-year prospective study of patients hospitalized with suicidal ideation American Journal of Psychiatry. 142(5):1985;559-563.
13. Bellivier F., Leboyer M., Courtet P., Buresi C., Beaufits B., Samolyk D.et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Archives of General Psychiatry. 55:1998;33-37.
14. Bellivier F., Szoke A., Henry C., Lacoste J., Bottos C., Nosten-Bertrand M.et al. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biological Psychiatry. 48:2000;319-322.
15. Bennett P.J., McMahon W.M., Watabe J., Achilles J., Bacon M., Coon H.et al. Tryptophan hydroxytase polymorphisms in suicide victims. Psychiatr. Genet. 10:2000;13-17.
16. Bligh-Glover W., Kolli T.N., Shapiro-Kulnane L., Dilley G.E., Friedman L., Balraj E.et al. The serotonin transporter in the midbrain of suicide victims with major depression. Biological Psychiatry. 47:2000;1015-1024.
17. Boldrini M, Underwood MD, Kassir SA, Bakalian MJ, Placidi GF, Sorbi S, et al. Increased tryptophan hydroxylase concentration in the brainstem raphe nuclei of depressed suicide victims compared to controls. ACNP 40th Annual Meeting, 2001.
18. Bondy B., Kuznik J., Baghal I., Schute C., Zwanzger P., Minov C.et al. Lack of association of serotonin-2A receptor gene polymorphism (Ti 02C) with suicidal ideation and suicide. American Journal of Medical Genetics. 96:2000;831-835.
19. Brunner H.G., Nelen M., Breakefied X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 262:1993;578-580.
20. Brunner H.G., Nelen M.R., van Zandvoort P., Abeling N.G., van Gennip A.H., Wolters E.C.et al. X-linked borderline mental retardation with prominent behavioral disturbance. phenotype, genetic localization, and evidence for disturbed monoamine metabolism American Journal of Human Genetics. 52:1993;1032-1039.
21. Buresi C., Courtet Ph., Leboyer M., Feingold J., Malafosse A. Association between suicide attempt and the trytophane hydroxylase (TPH) gene. American Journal of Human Genetics. 1997;A270.
22. Cao L., Li T., Xu K., Liu X. Association analysis of attempted suicide and 5-HT2A receptor gene. Zhonhua Yi.Xue Yi.Chuan Xue.Za Zhi. 18:2001;195-197.
23. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S.et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science. 268:1995;1763-1766.
24. Chong S.-A., Lee W.-L., Tan C.-H., Tay A.H.N., Chan A.O.M., Tan E.-C. Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Research. 97:2000;101-106.
25. Collier D.A., Stöber G., Li I., Heils A., Catatano M., Bella D.D.et al. A novel functional polymorphism within the promoter of the serotonin transporter gene. possible role in susceptibility to affective disorders Molecular Psychiatry. 1:1996;453-460.
26. Courtet P., Baud P., Abbar M., Boulenger J.P., Castelnau D., Mouthon D.et al. Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Mol. Psychiatry. 6:2001;338-341.
27. 1B serotonin receptors. Nature Genet. 14:1996;98-101.
28. Cravchik A., Goldman D. Neurochemicat individuality. genetic diversity among human dopamine and serotonin receptors and transporters Archives of General Psychiatry. 57:2000;1105-1114.
29. Crawford J., Sutherland G.R., Goldney R.D. No evidence for association of 5-HT2A receptor polymorphism with suicide. American Journal of Medical Genetics. 96:2000;879-880.
30. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D.et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 8:1999;621-624.
31. Demchyshyn L., Sunahara R.K., Miller K., Teitler M., Hoffman B.J., Kennedy J.L.et al. A human serotonin 1D receptor variant (5HT1Dβ) encoded by an intronless gene on chromosome 6. Proc. Natl. Acad. Sci. USA. 89:1992;5522-5526.
32. Du L., Bakish D., Lapierre Y.D., Ravindran A.V., Hrdina P.D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics. 96:2000;56-60.
33. Du L., Faludi G., Palkovits M., Bakish D., Hrdina P.D. Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicide. Int. J. Neuropsychopharmacol. 3:2000;215-220.
34. Du L., Faludi G., Palkovits M., Demeter E., Bakish D., Lapierre Y.D.et al. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biological Psychiatry. 46:1999;196-201.
35. Faludi G., Du L., Palkovits M., Antal B., Sotonyi P., Hrdina P.D. Serotonin transporters, serotonin-2A receptor and tryptophan hydroxilase gene polymorphisms in depressed suicide victims. Neurobiology (Bp). 8:2000;269-271.
36. Forsgren T., Van Gestel S., Åberg A.-C., Iksson A., n Broeckhoven C., Olfsson R. Evidence for different genetic variability in serotonergic and sopaminergic transmission in completed suicide and suicide attempters. Mol. Psychiatry. 4(Suppl.):1999;S23-S24.
37. Furlong R.A., Ho L., Rubinsztein J.S., Walsh C., Paykel E.S., Rubinsztein D.C. No association of the tryptophan hydroxylase gene with bipolar affective disorder, uni polar affective disorder, or suicidal behaviour in major affective disorder. American Journal of Medical Genetics. 81:1998;245-247.
38. Garfinkel B.D., Froese A., Hood J. Suicide attempts in children and adolescents. American Journal of Psychiatry. 139:1982;1257-1261.
39. Geijer I., Frisch A., Persson M.L., Wasserman D., Rockah A., Michaelovsky E.et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr. Genet. 10:2000;19-26.
40. Gershon E.S. Genetics. Goodwin F.K., Jamison K.R. Manic-depressive illness. 1990;Oxford University Press, New York, Oxford.
41. Gorwood P., Batel P., Ades J., Hamon M., Boni C. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biological Psychiatry. 48:2000;259-264.
42. 1D-type serotonin receptor. Molecular Pharmacology. 40:1991;143-148.
43. Hong C.J., Tsai S.J., Wang Y.C. Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophrenia Research. 49:2001;59-63.
44. Hoyer D., Middlemiss D.N. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends in Pharmacological Sciences. 10:1989;130-132.
45. 2 sites in cortex and amygdata Brain Research. 614:1993;37-44.
46. Huang Y., Grailhe A., Arango V., Hen A., Mann J.J. Relationship of psychopathology to the human serotoninia genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology. 21:1999;238-246.
47. Kelsoe J.R., Remick R.A., Sadovnick A.D., Kristbjamarson H., Flodman P., Spence M.A.et al. Genetic linkage study of bipolar disorder and the serotonin transporter. American Journal of Medical Genetics. 67:1996;215-217.
48. Kirov G., Owen M.J., Jones I., McCandless F., Craddock N. Tryptophan hydroxylase gene and manic-depressive illness. Archives of General Psychiatry. 56:1999;98-99.
49. Kunugi H., Hattori M., Kato T., Tatsumi M., Sakaki I., Hirose I.et al. Serotonin transporter gene polymorphisms. ethnic difference and possible association with bipolar affective disorder Molecular Psychiatry. 2:1997;457-462.
50. Kunugi H., Ishida S., Kato T., Sakai I., Tatsumi M., Hirose I.et al. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. American Journal of Psychiatry. 156:1999;774-776.
51. 3H]imipramine binding in rat hypothalamus. Association with uptake of serotonin but not of norepinephrine Science. 210:1980;1133-1135.
52. 1Dβ autoreceptor gene on chromosome 6 and direct analysis for sequence variants. American Journal of Medical Genetics. 60:1995;157-161.
53. 1B receptor gene in 2 population. Archives of General Psychiatry. 55:1998;989-994.
54. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S.et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
55. 1D subtype. Journal of Biological Chemistry. 267:1992;7553-7562.
56. 1D binding in globus pallidus but not cortex Molecular Psychiatry. 2:1997;314-321.
57. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computer tomography. Biological Psychiatry. 44:1998;1090-1098.
58. Mann J.J. The neurobiology of suicide. Nature Med. 4:1998;25-30.
59. Mann J.J., Arango V., Marzuk P.M., Theccanat S., Reis D.J. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies. Br. J. Psychiatry Suppl. 1989;7-14.
60. Mann J.J., Brent D.A., Arango V. The neurobiology and genetics of suicide and attempted suicide. a focus on the serotonergic system Neuropsychopharmacotogy. 24:2001;467-477.
61. Mann J.J., Huang Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry. 57:2000;729-738.
62. Mann J.J., Malone K.M., Nielsen D.A., Goldman D., Erdos J., Geternter J. Possible association of a polymorphism of the tryptophan hydroxytase gene with suicidal behavior in depressed patients. American Journal of Psychiatry. 154:1997;1451-1453.
63. Mann J.J., McBride P.A., Brown R.P., Linnoila M., Leon A.C., DeMeo M.D.et al. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Archives of General Psychiatry. 49(6):1992;442-446.
64. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry. 43:1986;954-959.
65. Mann J.J., Waternaux C., Haas G.L., Malone K.M. Towards a clinical model of suicidal behavior in psychiatric patients. American Journal of Psychiatry. 156:1999;181-189.
66. Martin G.R., Humphrey P.P.A. Receptors for 5-hydroxytryptamine. current perspectives on classification and nomenclature Neuropharmacology. 33:1994;261-273.
67. Mockus S.M., Vrana K.E. Advances in the molecular characterization of tryptophan hydroxylase [review]. Journal of Molecular Neuroscience. 10:1998;163-179.
68. New A.S., Gelernter J., Goodman M., Mitropoulou V., Koenigsberg H., Silverman J.et al. Suicide, impulsive aggression, and HTR1 B genotype. Biological Psychiatry. 50:2001;62-65.
69. Nielsen D.A., Dean M., Goldman D. Genetic mapping of the human tryptophan hydroxylase gene on chromosome II, using an intronic conformational polymorphism. American Journal of Human Genetics. 51:1992;1366-1371.
70. Nielsen D.A., Goldman O., Virkkunen M., Tokola A., Rawlings A., Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxytase polymorphism. Archives of General Psychiatry. 51:1994;34-38.
71. Nielsen D.A., Jenkins G.L., Stefanisko K.M., Jefferson K.K., Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Molecular Brain Research. 45:1997;145-148.
72. Nielsen D.A., Virkkunen M., Lappatainen J., Eggert M., Brown G.L., Long J.C.et al. A tryptophan hydroxylase gene marker for suicidatity and alcoholism. Archives of General Psychiatry. 55:1998;593-602.
73. 1B receptor gene polymorphism and suicide victims in a Japanese population. American Journal of Medical Genetics. 105:2001;343-345.
74. 1A receptor gene structural polymorphisms and suicide victims. American Journal of Medical Genetics. 114:2002;423-425.
75. Nordstrom P., Samuelsson M., Asberg M., Trãskman-Bendz L., Aberg-Wistedt A., Nordin C.et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide and Life-Threatening Behavior. 24:1994;1-9.
76. Nöthen M.M., Erdmann J., Shimron-Abarbanelt O., Propping P. Identification of genetic variation in the human serotonin 1 Dβ receptor gene. Biochemical and Biophysical Research Communications. 205:1994;1194-1200.
77. Ohara K., Nagai M., Tsukamoto I., Tani K., Suzuki Y. Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorder. Biological Psychiatry. 44:1998;550-554.
78. Ono H., Shirakawa O., Kitamura N., Hashimoto T., Nishiguchi N., Nishimura A.et al. Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol. Psychiatry. 7:2002;1127-1132.
79. Ono H., Shirakawa O., Nishiguchi N., Nishimura A., Nushida H., Ueno Y.et al. Tryptophan hydroxylase gene polymorphisms are not associated with suicide. American Journal of Medical Genetics. 96:2000;861-863.
80. Ono H., Shirakawa O., Nishiguchi N., Nishimura A., Nushida H., Ueno Y.et al. Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J. Psychiatr. Res. 35:2001;173-176.
81. Paik I., Toh K., Kim J., Lee C. TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Human Heredity. 50:2000;365-369.
82. Pandey G.N. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Annals of the New York Academy of Sciences. 836:1997;182-183.
83. Parsey RV, Arango V, Simpson N, Huang Y, Dwork AJ, Laruelte M, et al. Serotonin transporter changes associated with major depression and suicide. ACNP 39th Annual Meeting, San Juan, Puerto Rico 2000. p. 300.
84. Paul S.M., Rehavi M., Skolnick P., Goodwin F.K. High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet; studies in depression. Post A.M., Bellinger C.J. Neurobiology of mood disorders. 1984;Williams and Wilkins, Baltimore.
85. Pfeffer C.R., Normandin L., Kakuma T. suicidal children grow up. suicidal behavior and psychiatric disorders among relatives Journal of American Academy of Child and Adolescent Psychiatry. 33:1994;1087-1097.
86. Phillips T.J., Hen R., Crabbe J.C. Complications associated with genetic background effects in research using knockout mice. Psychopharmacology. 147:1999;5-7.
87. Preuss U.W., Koller G., Bahlmann M., Soyka M., Bondy B. No association between suicidal behavior and 5-HT2A-T102C polymorphism in alcohol dependents. American Journal of Medical Genetics. 96:2000;877-878.
88. 1B receptor knock out - behavioral consequences. Behavioral Brain Research. 73:1996;305-312.
89. Rees M., Norton N., Jones I., McCandless F., Scourtield J., Holmans P.et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT;5HTT). Molecular Psychiatry. 2:1997;398-402.
90. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Crabbe J.C.et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature. 393:1998;176-178.
91. Rosenthal N.E., Mazzanti C.M., Barnett R.L., Hardin T.A., Turner E.H., Lam G.K.et al. Rote of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonal affective disorder. Molecular Psychiatry. 3:1998;175-177.
92. Rotondo A., Schuebel K., Bergen A., Aragon R., Virkkunen M., Linnoila M.et al. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Molecular Psychiatry. 4:1999;360-368.
93. Roy A. Genetic and biologic risk factors for suicide in depressive disorders. Psychiatric Quarterly. 64:1993;345-358.
94. Roy A., De Jong J., Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Archives of General Psychiatry. 46:1989;609-612.
95. Roy A., Rytander G., Sarchiapone M. Genetics of suicide. Family studies and molecular genetics. Annals of the New York Academy of Sciences. 836:1997;135-157.
96. Roy A., Segal N.L., Sarchiapone M. Attempted suicide among living co-twins of twin suicide victims. American Journal of Psychiatry. 152:1995;1075-1076.
97. Rujescu D., Giegling I., Sato I., Moeller H.J. A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatr. Genet. 11:2001;169-172.
98. Russ M.J., Lachman H.M., Kashdan I., Saito T., Bajmakovic-Kacila S. Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide. Psychiatry Research. 93:2000;73-78.
99. Sabot S.Z., Hu S., Hamer O. A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics. 103:1998;273-279.
100. 1B receptor. Science. 265:1994;1875-1878.
101. 1B) not linked to schizophrenia in five Canadian pedigrees. Human Heredity. 43:1993;315-318.
102. Soucy J.-P., Lafaille F., Lemoine P., Mrini A., Descarries L. Validation of the transporter ligand cyanoimipramine as a marker of serotonin innervation density in brain. Journal of Nuclear Medicine. 35:1994;1822-1830.
103. Souery D., Van Gestel S., Massat I., Btairy S., Adolfsson A., Btackwood O.et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders. a multicenter association study Biological Psychiatry. 49:2001;405-409.
104. Spurlock G., Heils A., Holmans P., Williams J., D'Souza U.M., Cardno A.et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol. Psychiatry. 3:1998;42-49.
105. Statham D.J., Heath A.C., Madden P.A.F., Bucholz K.K., Biesrut L., Dinwiddie S.H.et al. Suicidal behaviour. an epidemiological and genetic study Psychological Medicine. 28:1998;839-855.
106. Terwittiger J.D., Goring H.H.H. Gene mapping in the 20th and 21st centuries. statistical methods, data analysis, and experimental design Human Biology. 72:2000;63-132.
107. Träskman-Bendz L., Alling C., Oreland L., Regnéll G., Vinge E., Ohman R. Prediction of suicidal behavior from biologic tests. Journal of Clinical Psychopharmacology. 12(Suppl.):1992;21S-26S.
108. Tsai S.J., Hong C.J., Wang Y.C. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport. 10:1999;3773-3775.
109. Turecki G., Briere A., Dewar K., Antonetti I., Lesage A.D., Seguin M.et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. American Journal of Psychiatry. 156:1999;1456-1458.
110. Turecki G., Zhu Z., Tzenova J., Lesage A., Seguin M., Tousignant M.et al. IPH and suicidal behavior. a study in suicide completers Mol. Psychiatry. 6:2001;98-102.
111. Underwood M.D., Khaibulina A.A., Ellis S.P., Moran A., Rice P.M., Mann J.J.et al. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biological Psychiatry. 46:1999;473-483.
112. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Volts M., Fink H.et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 299:2003;76.
113. Warren J.T. Jr., Peacock M.L., Rodriguez L.C., Fink J.K. An Mspl polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Mol. Genet. 2:1993;338.
114. 1Dβ Proc. Natl. Acad. Sci. USA. 89:1992;3630-3634.
115. Whitaker-Azmitia PM, Peroutka SJ, editors. The neuropharmacology of serotonin, vol. 600, 1990.
116. 1A receptor is intact in mood disorders. Neuropsychopharmacology. 12:1995;263-268.
117. Zalsman G., Frisch A., Bromberg M., Geternter J., Michaelovsky E., Campino A.et al. Family-based association study of serotonin transporter promoter in suicidal adolescents. no association with suicidatity but possible role in violence traits American Journal of Medical Genetics. 105:2001;239-245.
118. Zalsman G., Frisch A., King R.A., Pauls D.L., Grice D.E., Geternter J.et al. Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents. American Journal of Medical Genetics. 105:2001;451-457.